Rankings
▼
Calendar
IRWD Q1 2016 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$66M
Gross Profit
$34M
51.8% margin
Operating Income
-$2M
-3.0% margin
Net Income
-$13M
-20.1% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$161,000
Free Cash Flow
-$847,000
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$603M
Total Liabilities
$512M
Stockholders' Equity
$91M
Cash & Equivalents
$281M
← FY 2016
All Quarters
Q2 2016 →
